In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites. - Wikidata - wikimedia - TriplyDB

In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.

In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.

http://www.wikidata.org/entity/Q37263372

about

Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Drugs in development for toxoplasmosis: advances, challenges, and current status.Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models.Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.

P2860

Q27682650-97FBB0FC-8493-492E-BCA1-683552833D83 Q35547951-9DCF8F4A-D06D-4BB3-9685-0AD738FFFE56 Q36076061-8DCD0176-BD38-4DBE-84B9-7DF3636D1B90 Q37428599-FCE885DD-02B7-4A4D-BA2A-541B0E753FA7 Q37594988-FE373969-0A3B-4661-9F5E-0A9E8F6CE039 Q37613765-9266F5CE-DFF3-4E40-AF09-237C72BB38C8 Q38655231-4C1EEC93-F8C3-4664-8A6C-C69DF9CFC47A Q50288394-EB7C7249-5151-4430-BE78-778859B63A43

P2860

In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.

http://www.wikidata.org/entity/Q37263372

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@en

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@nl

type

label

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@en

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@nl

prefLabel

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@en

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@nl

P1433

Q37263372-322EE00A-20BB-47D4-9F51-6ADB438FF144

P1476

Q37263372-25624946-30CF-4402-AFF1-35004F29B075

P2093

Q37263372-18C55DFA-0903-4666-AFF3-5BCFF1EEAE1A

Q37263372-2C6F33CA-CDED-4756-97FB-A522EBFCC235

Q37263372-BA565E17-AF87-42F7-B36E-68D83CEA719B

Q37263372-CCDDC6FB-5FAE-429E-B71D-1DDD4565DE23

Q37263372-D86BCBA5-A6AA-4BB7-9B02-0D2727B60B9D

P2860

Q37263372-024CE07F-BE37-4494-9C7D-0ADD0C8FAE5E

Q37263372-0A597B65-C0B7-493A-BC9D-E8F0AFEA2916

Q37263372-15C2B486-C3D2-4656-8764-D72F97283A6F

Q37263372-16B6C9EE-5FCB-48C1-9CED-1D8D3963D196

Q37263372-1A841B8A-BDEF-4249-8D62-111A476175A9

Q37263372-1B47CD57-697C-4025-B167-412F91E269BE

Q37263372-1E053084-6203-432D-BD8F-1C85F60FBA99

Q37263372-1F3067B0-A37C-4BDA-9E69-A96BCBBAD16A

Q37263372-2C651FFF-2F7E-488F-B8FD-2B967A429412

Q37263372-2E7D0736-F524-423C-B5A7-DEADEF92E4E9

P304

Q37263372-6531550B-D15F-4980-A95A-BC3983BA06B4

P31

Q37263372-9725A3B5-0159-4860-8361-3D56788F0FE4

P356

Q37263372-5457A73B-A16A-4219-902A-E4EC8B7EBBE1

P407

Q37263372-4EEA983A-8445-4DAE-B0D6-EFA64E3ED982

P433

Q37263372-2250F5F9-925F-4A91-B4A5-24FF9D031DDD

P478

Q37263372-7B4FD499-EBFD-4B72-BF9F-12BC3B6126A7

P577

Q37263372-7655C192-953D-4C99-83D4-461467392485

P698

Q37263372-8E271325-F891-4066-B0EA-2887CA3D5F47

P921

Q37263372-7EB5BD3E-4405-4850-83DD-5E90033F4C8A

Q37263372-C00AD774-AE86-4F39-84DE-F4701641A737

P932

Q37263372-F23CE0DE-1F47-454B-A768-93FADC4A6E7E

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro effects of novel ruth ...... Toxoplasma gondii tachyzoites.

@en

P2093

Andrew Hemphill

http://www.w3.org/2001/XMLSchema#string

Carsten A Vock

http://www.w3.org/2001/XMLSchema#string

Fabienne Barna

http://www.w3.org/2001/XMLSchema#string

Karim Debache

http://www.w3.org/2001/XMLSchema#string

Tatiana Küster

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy

Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.

Epidemiology and control of neosporosis and Neospora caninum.

Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice.

Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity.

Novel arylimidamides for treatment of visceral leishmaniasis.

The antimalarial ferroquine: from bench to clinic.

Organometallic anticancer compounds

P304

5747-5754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02446-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23979747

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

Neospora caninum

P932

3811262

http://www.w3.org/2001/XMLSchema#string